Target intelligence / Profile preview

Alpha-glucosidase 1 (Cqm1) (Cqm1)

Target
Cqm1
Molecular classification
Enzyme, Receptor, GPI-anchored protein, Hydrolase
01

Overview

The alpha-glucosidase-like GPI-anchored Bin receptor, primarily known as Cqm1 or Cpm1, is a membrane-bound enzyme located in the midgut of mosquito larvae, particularly Culex species (Darboux et al., 2001, J. Biol. Chem.). While its physiological role involves the hydrolysis of maltose into glucose, it serves as the primary target for the binary toxin (Bin) produced by the bacterium Lysinibacillus sphaericus (Ferreira et al., 2010, Insect Biochem. Mol. Biol.). The toxin consists of two subunits, BinA and BinB; BinB specifically recognizes and binds to this GPI-anchored receptor, allowing the toxic BinA subunit to internalize or form pores, ultimately causing midgut epithelial damage and larval death (Opota et al., 2008, Cell. Microbiol.). This interaction is a cornerstone of biological mosquito control programs aimed at reducing the transmission of diseases like West Nile virus and lymphatic filariasis. Resistance to these bio-insecticides often arises from mutations in the gene encoding this receptor, which can lead to the loss of the GPI anchor or altered binding affinity (Silva-Filha et al., 2004, Appl. Environ. Microbiol.). Because the receptor is highly specific to certain mosquito species, the Bin toxin is considered an environmentally friendly alternative to chemical pesticides.

Other names
Cpm1Maltase 1Bin receptorAlpha-glucosidase-like GPI-anchored proteinLysinibacillus sphaericus binary toxin receptor
02

Mechanism of action

The BinB component of the Lysinibacillus sphaericus binary toxin binds to the GPI-anchored alpha-glucosidase receptor on the larval midgut epithelium, facilitating the action of the BinA toxin which leads to pore formation, cell lysis, and death of the mosquito larva.

03

Biological functions

Carbohydrate metabolismMaltose hydrolysisToxin binding
04

Disease associations

Infection (Vector control)Lymphatic filariasisWest Nile virus
05

Safety considerations

Insecticide resistanceTarget specificity
06

Interacting drugs

Lysinibacillus sphaericus binary toxin

2 more in the full profile.

07

Biomarkers

cqm1 gene mutationsAlpha-glucosidase activity levels

Beyond the preview

Go deeper on Alpha-glucosidase 1 (Cqm1) (Cqm1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-glucosidase 1 (Cqm1) (Cqm1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call